CONNECT WITH US:
Dec, 17 2018 09:00 JST
Novotech CRO Launches Largest Oracle Trial Management and Monitoring Cloud Service Implementation in Asia-Pacific
SYDNEY, Dec, 17 2018 - (ACN Newswire) - Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investment program that it has implemented the Oracle's Trial Management and Monitoring Cloud Service (TMMCS) to support its growth in the Asia-Pacific.
StemLab CEO Donghoon Oh (Left) and Novotech CEO Dr John Moller (centre) at a recent client presentation in Asia-Pacific.
Oracle Health Sciences VP of Services, David Tuckfield said Novotech will have the largest TMMCS implementation in the Asia-Pacific and is the first biotech-focused CRO in the region to go-live on Oracle's TMMCS technology in the cloud.
"We are delighted to be able to implement Novotech's vision of next generation trial management," he added.
Novotech, the recipient of the 2018 Frost & Sullivan Asia-Pacific Biotech CRO Company of the Year award for the 3rd consecutive year, has been operating in the Asia-Pacific for 22 years.
Novotech CEO Dr John Moller said Novotech has always invested heavily in the latest technology. This ensures regulatory compliance, allows integration into global studies, and gives Novotech teams and clients better data visibility to improve decision-making.
"Oracle's cloud technology provides a centralized trial database enabling improved access, control and governance of clinical data. The system is highly configurable allowing us to tailor process flows and alerts to client needs, as well as ensuring effective control on deviations. Advanced functionalities like eSignatures, and tools for swift approvals and submissions help us accelerate trial implementation."
Novotech launched the migration project in partnership with Oracle Health Science Global Services in March 2018. Novotech has also invested in Oracle Argus for Medical Safety and Oracle Inform EDC.
Novotech is a full service CRO with on-the-ground operations in Australia, New Zealand, South Korea, China, Taiwan, Philippines, Hong Kong, Singapore, Malaysia, Thailand and India with 550+ full-time employees.
Novotech clinical staff numbers have grown by more than 20% in Asia over the last quarter, fueled by demand for a regional CRO with international accreditation and reputation, combined with local knowledge, partnerships and expertise.
The CRO has extensive therapeutic area experience handling clinical studies with small and mid-size biotechnology companies across all phases of clinical trials - First-in-Human (FIH) studies to phase IV. Novotech has managed around 700 projects including the APAC component of pivotal trials for multiple FDA, EMA registered products since 2001
Novotech has now signed 10 strategic collaborations with hospitals and research institutions in the Asia-Pacific region.
About Oracle TMMCS
Oracle Health Sciences Trial Management and Monitoring Cloud Service, enables effective management of critical clinical trial activities and improved relationships with investigators, from early to late-stage clinical trials. With real-time visibility into clinical trial progress and significant utilization rates of clinic and staff resources, this solution can help to lower costs, while increasing study speed and data quality. These services are part of the foundation for Oracle Health Sciences' integrated, holistic approach to risk-based monitoring.
About Novotech -
Headquartered in Sydney, Novotech is internationally recognized as the leading regional full-service contract research organization (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.
Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech's strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.
For Media enquiries:
Susan Fitzpatrick-Napier, AU: +61 2 8218 2144
USA: +1 415 951 3228, Asia: +65 3159 3427
Copyright ©2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Toyota Yaris WRC Set for Crucial Mixed-surface Spectacular
Oct 18, 2019 17:37 JST
Overview of Honda Exhibits at the 26th ITS World Congress 2019 in Singapore
Oct 18, 2019 15:46 JST
Hitachi Automotive Systems Starts Mass Production of High Voltage and High Output EV Inverter, the First in the World
Oct 18, 2019 15:33 JST
Hitachi Launches Dashboard for Building Owners and Managers to Check the Operation and Maintenance Status of Building Facilities, Including Elevators
Oct 18, 2019 09:03 JST
Toyota to Show Production-Ready Ultra-Compact BEV at 2019 Tokyo Motor Show "FUTURE EXPO"
Oct 17, 2019 13:48 JST
Monumental Sports & Entertainment, NEC Announce Partnership with Washington Wizards
Oct 16, 2019 17:45 JST
NEC Announces First International Partnership with Professional Basketball Player Rui Hachimura
Oct 16, 2019 17:33 JST
Hitachi and Frasers Property Sign S$100 Million MOU to Drive Digital Transformation in the Real Estate Industry in Asia Pacific
Oct 16, 2019 16:02 JST
Toyota's New Model Yaris Makes World Premiere
Oct 16, 2019 15:32 JST
Ministry of Movement and NEC to Collaborate on Future of Urban Mobility
Oct 16, 2019 15:04 JST
Eisai's New Drug Approval for Fycompa for Adjunctive Treatment of Partial Onset Seizures in China
Oct 15, 2019 21:24 JST
Fujitsu's Gymnastics Judging Support System Wins the "Minister of Internal Affairs and Communications Award" at CEATEC 2019
Oct 15, 2019 16:25 JST
Fujitsu Develops AI based Facial Expression Recognition Technology to Accurately Detect Subtle Changes in Expression
Oct 15, 2019 16:09 JST
Toyota Rolls Out New Compact Convertible Sports Car "Copen GR SPORT" in Japan
Oct 15, 2019 14:09 JST
Mazda Publishes Mazda Sustainability Report 2019 and Annual Report 2019
Oct 15, 2019 13:27 JST
Mazda Included in Dow Jones Sustainability Asia Pacific Index for Third Year Running
Oct 15, 2019 13:16 JST
Toyota: 'People of the Future' to Welcome Visitors at 'Mobility Theme Park'
Oct 11, 2019 16:14 JST
Toyota to Unveil Next-Generation "Mirai Concept" at 2019 Tokyo Motor Show's "Future Expo"
Oct 11, 2019 13:45 JST
Hitachi Expands Its Elevators & Escalators Business in Laos
Oct 10, 2019 19:53 JST
MHIENG Completes First Delivery of 7000-Series New-Series Carriages for Hiroshima Rapid Transit's "Astram Line"
Oct 10, 2019 16:11 JST
More Latest Release >>
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research
July 11 2019 11:00 JST
Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO
May 31 2019 07:00 JST
Novotech CRO strengthens South Korean Clinical Capabilities, partners with 2 Major Hospitals
April 18 2019 04:00 JST
Novotech CNS USA Appoints Dr Robert Malone to its Washington, DC BioDesk
March 25 2019 18:00 JST
Novotech CRO Announces 41 Clinical Staff and 81 Projects in South Korea
November 28 2018 11:02 JST
Novotech and CNS deal expands CRO services for Biopharma Clients across Asia-Pacific
October 19 2018 07:00 JST
Novotech the Asia-Pacific CRO named Top 10 CRO
August 23 2018 13:00 JST
Sponsors Recommend Novotech for CRO Leadership Award
August 09 2018 13:00 JST
Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials
July 19 2018 06:00 JST
Novotech at DIA18 announces Asia Partnerships on Target to Reach 1.4 Bil Patients
June 28 2018 06:00 JST
More Press release >>